Published in Clin Infect Dis on April 01, 1993
Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J Clin Microbiol (1995) 2.43
Rapid and accurate identification of Staphylococcus species by tRNA intergenic spacer length polymorphism analysis. J Clin Microbiol (1997) 1.69
Clotting activity in Staphylococcus schleiferi subspecies from human patients. J Clin Microbiol (1994) 1.42
Glyceraldehyde-3-phosphate dehydrogenase-encoding gene as a useful taxonomic tool for Staphylococcus spp. J Clin Microbiol (2000) 1.16
Identification of Staphylococcus spp. by PCR-restriction fragment length polymorphism of gap gene. J Clin Microbiol (2001) 1.05
Staphylococcus schleiferi subsp. schleiferi expresses a fibronectin-binding protein. Infect Immun (1999) 0.98
Case of Staphylococcus schleiferi endocarditis and a simple scheme to identify clumping factor-positive staphylococci. J Clin Microbiol (1999) 0.96
First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organism. Diagn Microbiol Infect Dis (2012) 0.88
A ferret model of COPD-related chronic bronchitis. JCI Insight (2016) 0.81
Biotic and abiotic factors affecting plasmid transfer in Escherichia coli strains. Appl Environ Microbiol (1992) 1.46
[Resistance in Haemophilus influenzae in Spain. 2d study (1990)]. Enferm Infecc Microbiol Clin (1993) 1.39
Serratia rubidaea as an invasive pathogen. J Clin Microbiol (1996) 1.09
Orogenital transmission of Neisseria meningitidis serogroup C confirmed by genotyping techniques. Eur J Clin Microbiol Infect Dis (2005) 1.03
Detection of anti-interferon-gamma autoantibodies in subjects infected by Mycobacterium tuberculosis. Int J Tuberc Lung Dis (1998) 1.02
Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis. Eur J Clin Microbiol Infect Dis (1990) 1.02
[The impact of COPD on hospital resources: the specific burden of COPD patients with high rates of hospitalization]. Arch Bronconeumol (2001) 1.01
Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis. Eur J Clin Microbiol (1987) 1.01
In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents. Eur J Clin Microbiol Infect Dis (1990) 0.98
Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea. Trans R Soc Trop Med Hyg (1999) 0.95
Vulvovaginal candidiasis refractory to treatment with fluconazole. Eur J Obstet Gynecol Reprod Biol (1992) 0.92
Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis. J Clin Microbiol (1999) 0.92
Endocarditis due to Staphylococcus capitis subspecies ureolyticus. Clin Infect Dis (1993) 0.90
Acute pancreatitis associated with Campylobacter jejuni bacteremia. Clin Infect Dis (1992) 0.90
Candidal infection of bone. Assessment of serologic tests in diagnosis and management. Diagn Microbiol Infect Dis (1991) 0.90
Fatal intravascular hemolysis in a patient with Clostridium perfringens septicemia. Clin Infect Dis (1995) 0.88
Identification of antigens reacting with anti-Candida albicans germ tube antibodies. Eur J Epidemiol (1992) 0.85
Kinetics and regulation of NK activity by interleukin-2 and interferon in acute toxoplasmosis. Scand J Immunol (1991) 0.84
Influence of mite growth culture phases on the biological standardization of allergenic extracts. J Investig Allergol Clin Immunol (1998) 0.83
Relationship between the production of interferon-alpha/beta and interferon-gamma during acute toxoplasmosis. Parasitology (1989) 0.83
Colony morphotype on Sabouraud-triphenyltetrazolium agar: a simple and inexpensive method for Candida subspecies discrimination. J Clin Microbiol (1992) 0.83
[Profile of bacterial isolates and antimicrobial susceptibility: Multicenter study using a one-day cut-off]. Rev Esp Quimioter (2000) 0.82
Multicenter evaluation of a fully automated screening test, VIDAS HIV 1 + 2, for antibodies to human immunodeficiency virus types 1 and 2. J Clin Microbiol (1994) 0.82
Detection of circulating antigens in the diagnosis of acute toxoplasmosis. Am J Trop Med Hyg (1994) 0.81
[Description of 165 episodes of fungemia: A multicenter study.]. Rev Iberoam Micol (1999) 0.81
Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands. Bioorg Med Chem Lett (1999) 0.80
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients. Eur J Clin Microbiol Infect Dis (1996) 0.80
Presence of HIV antigen p24 in the synovial fluid of a patient without antigenemia suffering from staphylococcal arthritis. AIDS (1991) 0.80
[Detection of hepatitis B virus DNA in peripheral blood mononuclear cells from patients with various hepatopathies using in situ hybridization]. An Med Interna (1991) 0.80
[Characteristics of intrafamilial transmission of the hepatitis B virus: a case load contribution and review of the literature]. Enferm Infecc Microbiol Clin (1989) 0.80
Immune responses to yeast and mycelial forms of Candida albicans in intraperitoneally infected mice. Mycopathologia (1986) 0.80
[Diagnosis of systemic candidiasis in parenteral drug addicts by detection of antimycelial antibodies]. Med Clin (Barc) (1988) 0.80
[Chronic granulomatous disease and pulmonary nocardiosis]. Med Clin (Barc) (1992) 0.79
Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS. Eur J Clin Microbiol Infect Dis (1994) 0.79
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy. Am J Gastroenterol (1999) 0.79
Chitin assay to estimate the growth of Candida albicans in organs of infected mice. J Med Vet Mycol (1991) 0.79
A case of meningitis due to "Streptococcus zooepidemicus". Clin Infect Dis (1993) 0.79
Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain. Eur J Clin Microbiol Infect Dis (1995) 0.79
[Effect of treatment with clindamycin, erythromycin, rifamycin or gentamicin on the ingestion capacity of peritoneal macrophages in mice]. Pathol Biol (Paris) (1990) 0.78
[Toxoplasma gondii. A challenge for the 90's]. Enferm Infecc Microbiol Clin (1993) 0.78
Detection of HGV in serum and peripheral blood mononuclear cells of maintenance haemodialysis patients. J Hosp Infect (1999) 0.78
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study. J Chemother (1997) 0.78
[Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. Rev Esp Quimioter (2006) 0.77
[Polymicrobial bacteremia caused by E. gergoviae and C. albicans]. Enferm Infecc Microbiol Clin (1991) 0.77
In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens. Eur J Clin Microbiol Infect Dis (2000) 0.77
Distribution of HCV genotypes in patients infected by different sources. Res Virol (1998) 0.77
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha. Eur J Clin Microbiol Infect Dis (1996) 0.77
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position. J Med Chem (2001) 0.77
Kinetics of allergen expression in cultures of house dust mites, Dermatophagoides pteronyssinus and D. farinae (Acari: Pyroglyphidae). J Med Entomol (1997) 0.77
Effects of fasting and immobilization stresses on the phagocytic capacity of rat polymorphonuclear phagocyte monolayers. Arch Immunol Ther Exp (Warsz) (1986) 0.76
A case of myiasis due to Dermatobia hominis. Eur J Clin Microbiol Infect Dis (1993) 0.76
Antibodies against Trichosporon beigelii in vaginal washings from asymptomatic women. J Med Microbiol (1989) 0.75
Pathogenetic role of Epstein-Barr virus in malignant lymphomas that develop in immunocompromised patients. Blood (1992) 0.75
Separate Nocardia infections in a patient with chronic granulomatous disease. J Clin Microbiol (2001) 0.75
Different antibody response against Candida albicans cell wall antigens in cervicovaginal secretions of patients with vulvovaginal candidiasis. Gynecol Obstet Invest (1990) 0.75
[Invasive aspergillosis in acquired immunodeficiency syndrome]. Enferm Infecc Microbiol Clin (1992) 0.75
Characterization of hepatitis B virus genotypes in chronically infected patients. Rev Esp Quimioter (2007) 0.75
Epstein-Barr virus infection: aetiological role versus coincidental event in Hodgkin's disease. J Pathol (1992) 0.75
[Production of hepatitis B virus from peripheral blood lymphocytes stimulated with phytohemagglutinin]. Enferm Infecc Microbiol Clin (1993) 0.75
[Bacteremia caused by Haemophilus influenzae with special reference to its relation to HIV infection]. Enferm Infecc Microbiol Clin (1994) 0.75
[Empyema by Aspergillus fumigatus in an AIDS patient]. Enferm Infecc Microbiol Clin (1999) 0.75
Five-year survey of cefotaxime resistance in Spain. Microb Drug Resist (1995) 0.75
[Alloiococcus otitidis: a more common microorganism than we thought?]. Enferm Infecc Microbiol Clin (1997) 0.75
[Transient bacteremia caused by Aeromonas jandaei]. Enferm Infecc Microbiol Clin (1997) 0.75
Diagnosis of candidosis by amplification of small subunit of 18S rRNA gene. Rev Iberoam Micol (1997) 0.75
[Intramuscular collection in a patient infected with HIV]. Enferm Infecc Microbiol Clin (1994) 0.75
[Isolation of Stomatococcus mucilaginosus from blood cultures]. Enferm Infecc Microbiol Clin (1993) 0.75
Detection of human immunodeficiency virus type 1 by PCR before seroconversion in high-risk individuals who remain seronegative for prolonged periods. Eur J Clin Microbiol Infect Dis (1994) 0.75
[Mobiluncus in a breast abscess]. Enferm Infecc Microbiol Clin (1993) 0.75
[Canaliculitis caused by Actinomyces israelii]. Enferm Infecc Microbiol Clin (1994) 0.75
[Bacterial pneumonia as a risk marker for new bacterial diseases in patients with HIV infection]. Enferm Infecc Microbiol Clin (1996) 0.75
[DNA probe for the detection of uropathogenic strains of P-fimbriated Escherichia coli]. Enferm Infecc Microbiol Clin (1993) 0.75
[Disseminated histoplasmosis in a patient infected with the HIV]. Enferm Infecc Microbiol Clin (1996) 0.75
[Cutaneous cryptococcosis in 2 patients with AIDS]. Rev Clin Esp (1996) 0.75
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment]. Enferm Infecc Microbiol Clin (1997) 0.75
In vitro activity of biapenem against beta-lactamase producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis (1994) 0.75
[Meningococcal sepsis without meningitis or cutaneous manifestations]. Enferm Infecc Microbiol Clin (1999) 0.75
[Oligonucleotide probes for the characterization of TEM-1 and TEM-2 beta lactamases in Salmonella strains]. Enferm Infecc Microbiol Clin (1993) 0.75
[Sensitivity of Mycobacterium tuberculosis in our environment]. Enferm Infecc Microbiol Clin (1996) 0.75
[Detection of virulence factors using DNA probes in uropathogenic strains of Escherichia coli]. Enferm Infecc Microbiol Clin (1994) 0.75
[Varicella pneumonia in the adult]. An Med Interna (1994) 0.75
Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain. Microb Drug Resist (1996) 0.75
Maxillary sinusitis caused by Nocardia nova. Clin Infect Dis (1996) 0.75
[Diagnosis of disseminated candidiasis. Overcoming a challenge]. Enferm Infecc Microbiol Clin (1993) 0.75
[Incidence of lymphoid neoplasms in patients with HIV infection]. Enferm Infecc Microbiol Clin (1994) 0.75
[Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis]. Enferm Infecc Microbiol Clin (1999) 0.75
[Bacteremia by Neisseria meningitidis serogroup W-135 in Spain]. Enferm Infecc Microbiol Clin (1999) 0.75
[Isolation of Campylobacter sputorum biovar sputorum from a bed sore]. Enferm Infecc Microbiol Clin (1997) 0.75
[Nosocomial infection]. Rev Clin Esp (1996) 0.75
[Serological parameters for the diagnosis and follow-up of toxoplasmosis. Experimental models]. Enferm Infecc Microbiol Clin (1994) 0.75
[Genetic typing by PCR of isolates of C. albicans obtained in a resuscitation unit]. Enferm Infecc Microbiol Clin (1998) 0.75
[Evaluation of mutations that confer resistance to nucleoside analogs and protease inhibitors in HIV-1-infected patients. Study Group on Resistance to Antiretroviral Agents]. Rev Esp Quimioter (1999) 0.75
[Historical cohort study on bacterial pneumonias as predictors of the progression of the human immunodeficiency virus disease]. Enferm Infecc Microbiol Clin (1997) 0.75